Virtual Reality to Reduce Anxiety, Agitation and Delirium in Critically Ill Patients
NCT: NCT07649876 · RECRUITING
Brief Summary
This is a pilot feasibility study examining the use of immersive virtual reality (VR) in adult intensive care unit (ICU) patients. The study evaluates whether brief, non-interactive VR sessions delivered using a commercially available standalone head-mounted display with calming, nature-based content can be delivered safely and effectively within routine SICU workflow. Exploratory objectives assess whether VR sessions are associated with changes in anxiety, agitation, delirium, pain, and sedative medication requirements. This research is not intended to evaluate the safety or effectiveness of the headset and/or the specific VR software used for the research
Frequently Asked Questions
What is Virtual Reality to Reduce Anxiety, Agitation and Delirium in Critically Ill Patients?
Virtual Reality to Reduce Anxiety, Agitation and Delirium in Critically Ill Patients is a clinical trial registered under NCT07649876. Current status: RECRUITING.
What is the status of NCT07649876?
The current status of NCT07649876 (Virtual Reality to Reduce Anxiety, Agitation and Delirium in Critically Ill Patients) is: RECRUITING.
When did Virtual Reality to Reduce Anxiety, Agitation and Delirium in Critically Ill Patients start?
Virtual Reality to Reduce Anxiety, Agitation and Delirium in Critically Ill Patients started on 2026-06-02.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.